This HTML5 document contains 45 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n9http://linked.opendata.cz/resource/drugbank/drug/DB01844/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB01844/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB01844/identifier/drugbank/
n17http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n16http://linked.opendata.cz/resource/drugbank/drug/DB01844/identifier/chemspider/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n15http://linked.opendata.cz/resource/drugbank/drug/DB01844/identifier/chebi/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/drug/DB01844/identifier/wikipedia/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB01844/identifier/kegg-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01844/identifier/pdb/

Statements

Subject Item
n2:DB01844
rdf:type
n3:Drug
n3:generalReferences
# Redlich CA, Beckett WS, Sparer J, Barwick KW, Riely CA, Miller H, Sigal SL, Shalat SL, Cullen MR: Liver disease associated with occupational exposure to the solvent dimethylformamide. Ann Intern Med. 1988 May;108(5):680-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/3358569
n3:group
experimental
owl:sameAs
n11:DB01844 n17:DB01844
dcterms:title
Dimethylformamide
adms:identifier
n6:Dimethylformamide n7:46506036 n8:DMF n9:6228 n12:DB01844 n13:C03134 n15:17741 n16:5993
n3:synthesisReference
Masao Saito, Kinichi Mizuno, Yuzi Onda, Tetsuo Aoyama, Kumiko Kato, "Process for producing dimethylformamide." U.S. Patent US4218398, issued August, 1933.
n3:IUPAC-Name
n4:271B4C23-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4C29-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4C28-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4C25-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4C26-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4C27-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4C38-363D-11E5-9242-09173F13E4C5 n4:271B4C21-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4C3B-363D-11E5-9242-09173F13E4C5 n4:271B4C1F-363D-11E5-9242-09173F13E4C5 n4:271B4C22-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4C20-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4C2F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4C30-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4C2A-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4C2B-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4C2D-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4C2C-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4C2E-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
68-12-2
n3:Bioavailability
n4:271B4C34-363D-11E5-9242-09173F13E4C5
n3:Boiling-Point
n4:271B4C3A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4C36-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4C37-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B4C39-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4C33-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4C32-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4C35-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4C24-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4C31-363D-11E5-9242-09173F13E4C5